Publications of U. Reichl

Poster (338)

2003
Poster
Hundt, B., Reichl, U., & Schänzler, A.Serum-free cultivation of CEF for vaccine production in microcarrier-systemsPresented at: 18th ESACT MeetingGranada, Spain, May 11, 2003.
Poster
Möhler, L., Bock, A., Sann, H., & Reichl, U.Mathematical Modeling of MDCK Cell Growth by the Use of On-line DataPresented at: DECHEMA Jahrestagung der BiotechnologenMunich, Germany, April 2, 2003.
Poster
Sann, H., Bock, A., & Reichl, U.Investigation of a new, sterile, deadvolume free sampling-system for universal applications, automated and suitable for online-analyzingPresented at: DECHEMA Jahrestagung der BiotechnologenMunich, Germany, April 2, 2003.
Poster
Schmidt, J. K., König, B., & Reichl, U.Cooperation and competition: studies on heterogeneous microbial culturesPresented at: Jahrestagung der Vereinigung für allgemeine und angewandte Mikrobiologie (VAAM)Berlin, Germany, March 23, 2003.
Poster
Sidorenko, Y., Sann, H., & Reichl, U.Structured model of Influenza virus replication in MDCK cellsPresented at: 11th Congress on biotechnologyBasel, Switzerland, August 24, 2003.
2002
Poster
Genzel, Y. & Reichl, U.Analysis of cell growth, virus replication and medium composition in equine influenza vaccine productionPresented at: IUMS 2002Paris, France, July 27, 2002.
Poster
Genzel, Y. & Reichl, U.Analysis of cell growth, virus replication and medium composition in equine influenza vaccine productionPresented at: GVC/Dechema Jahrestagungen 2002Wiesbaden, Germany, June 11, 2002.
2001
Poster
Genzel, Y., Voges, L., & Reichl, U.Development of bioprocess concepts on vaccine production: influenza virus as an examplePresented at: 17th ESACT MeetingTyloesand, Sweden, June 10, 2001.

Issue (1)

2015
Issue
Grabherr, R. & Reichl, U. (Eds.) (2015)Vaccine BiotechnologyBiotechnology Journal, 10 (5)doi: 10.1002/biot.201590010.

Editorial (2)

2021
Editorial
Rapp, E. & Reichl, U. (2021)Preface to Advances in GlycobiotechnologyAdvances in Glycobiotechnology, i-vi.
2015
Editorial
Grabherr, R. & Reichl, U. (2015)Can modern vaccine technology pursue the success of traditional vaccine manufacturing?Biotechnology Journal, 10(5), 657–658WILEY-VCH Verlag GmbH & Co. KGaA, Weinheimdoi: 10.1002/biot.201500184.

Patent (3)

2020
Patent
Kupke, S. Y., Frensing, T., Zmora, P., & Reichl, U. (2020)Protective Interfering Nucleic Acid Molecule And Virus - Like Particle, Virsl Vector, or Virus Particle Containing the same as well as Pharmaceutical Composition Containing the Protective Interfering Nucleic Acid and its use.
2019
Patent
Tapia, F., Genzel, Y., & Reichl, U. (2019)Plug Flow Tubular Bioreactor , System Containing the same and Method for Production of Virus.
Patent
Wolff, M. W., Pieler, M., Reichl, U., & Marichal-Gallardo, P. (2019)Method for the Separation of Virus Compositions Including Depletion and Purification thereof.

Preprint (5)

2024
Preprint
Hellwig, P., Dittrich, A., Heyer, R., Reichl, U., & Benndorf, D. (2024)Detection, isolation and characterisation of phage-host complexes using BONCAT and click chemistrybioRxivdoi: 10.1101/2024.02.13.580147.
Preprint
Karsten, C. B., Buettner, F. F. R., Cajic, S., Nehlmeier, I., Roshani, B., Klippert, A., Sauermann, U., Stolte-Leeb, N., Reichl, U., Gerardy-Schahn, R., Rapp, E., Stahl-Hennig, C., & Pöhlmann, S. (2024)Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivitybioRxivdoi: 10.1101/2024.01.02.572735.
2021
Preprint
Pelz, L., Rüdiger, D., Alnaji, F. G., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U. (2021)Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapybioRxivdoi: 10.1101/2021.02.08.430251 .
Preprint
Prerna , A., Bdeir, N., Gärtner, S., Reiter, S., Pelz, L., Felgenhauer, U., Reichl, U., Ludwig, S., Weber, F., Hoffmann, M., Winkler, M., & Pöhlmann , S. (2021)Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particlesbioRxivdoi: 10.1101/2021.09.20.461172 .
Preprint
Van Den Bossche, T., Kunath, B. J., Schallert, K., Schäpe, S. S., Abraham, P. E., Armengaud, J., Arntzen, M. Ø., Bassignani, A., Benndorf, D., Fuchs, S., Giannone, R. J., Griffin, T. J., Hagen, L. H., Halder, R., Henry, C., Hettich, R. L., Heyer, R., Jagtap, P., Jehmlich, N., Jensen, M., Juste, C., Kleiner, M., Langella, O., Lehmann, T., Leith, E., May, P., Mesuere, B., Miotello, G., Peters, S. L., Pible, O., Reichl, U., Renard, B. Y., Schiebenhoefer, H., Scryba, A., Tanca, A., Trappe, K., Trezzi, J.-P., Uzzau, S., Verschaffelt, P., von Bergen, M., Wilmes, P., Wolf, M., Martens, L., & Muth, T. (2021)Critical Assessment of Metaproteome Investigation (CAMPI): A Multi-Lab Comparison of Established WorkflowsbioRxivdoi: 10.1101/2021.03.05.433915 .
Go to Editor View